About Grand Prairie Dialysis Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Clinical Trials at Grand Prairie Dialysis Center
During the past decade, Grand Prairie Dialysis Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
2012-01-17
2014-02-28
Completed
320
A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With Epoetin
2012-05-31
2015-02-13
Completed
170
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Grand Prairie Dialysis Center"
#1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Grand Prairie Dialysis Center
According to Clinical.Site data, the most researched conditions in "Grand Prairie Dialysis Center" are
"Chronic Kidney Disease" (1 trials), "Chronic Renal Failure" (1 trials) and "Chronic Renal Failure Requiring Hemodialysis" (1 trials). Many other conditions were trialed in "Grand Prairie Dialysis Center" in a lesser frequency.
Clinical Trials Intervention Types at Grand Prairie Dialysis Center
Most popular intervention types in "Grand Prairie Dialysis Center" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Epoetin Hospira" (2 trials) and "Epogen Amgen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Grand Prairie Dialysis Center
The vast majority of trials in "Grand Prairie Dialysis Center" are
2 trials for "All" genders.
Clinical Trials Status at Grand Prairie Dialysis Center
Currently, there are NaN active trials in "Grand Prairie Dialysis Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Grand Prairie Dialysis Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Grand Prairie Dialysis Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".